ATE405582T1 - P53 bindende t-zellrezeptormoleküle und deren verwendungen - Google Patents
P53 bindende t-zellrezeptormoleküle und deren verwendungenInfo
- Publication number
- ATE405582T1 ATE405582T1 AT02746470T AT02746470T ATE405582T1 AT E405582 T1 ATE405582 T1 AT E405582T1 AT 02746470 T AT02746470 T AT 02746470T AT 02746470 T AT02746470 T AT 02746470T AT E405582 T1 ATE405582 T1 AT E405582T1
- Authority
- AT
- Austria
- Prior art keywords
- molecules
- protein
- tcr
- cell receptor
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29632401P | 2001-06-05 | 2001-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE405582T1 true ATE405582T1 (de) | 2008-09-15 |
Family
ID=31946570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02746470T ATE405582T1 (de) | 2001-06-05 | 2002-06-05 | P53 bindende t-zellrezeptormoleküle und deren verwendungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US7456263B2 (de) |
EP (2) | EP2009019A1 (de) |
JP (1) | JP4447456B2 (de) |
CN (1) | CN1692124B (de) |
AT (1) | ATE405582T1 (de) |
AU (1) | AU2002316190B8 (de) |
CA (1) | CA2487779C (de) |
DE (1) | DE60228504D1 (de) |
DK (1) | DK1546188T3 (de) |
ES (1) | ES2307770T3 (de) |
WO (1) | WO2004018619A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1289564B1 (de) * | 2000-06-05 | 2018-07-18 | Altor BioScience Corporation | T-zell-rezeptor fusionen und konjugate und verfahren zu deren verwendung |
EP1691661B1 (de) * | 2003-11-10 | 2014-01-08 | Altor BioScience Corporation | Lösliche tcr-moleküle und anwendungsverfahren |
WO2006036445A2 (en) | 2004-09-24 | 2006-04-06 | Trustees Of Dartmouth College | Chimeric nk receptor and methods for treating cancer |
US10464987B2 (en) | 2009-10-06 | 2019-11-05 | Abbvie Inc. | Human single-chain T cell receptors |
US9273283B2 (en) | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
WO2011059836A2 (en) | 2009-10-29 | 2011-05-19 | Trustees Of Dartmouth College | T cell receptor-deficient t cell compositions |
WO2013033626A2 (en) | 2011-08-31 | 2013-03-07 | Trustees Of Dartmouth College | Nkp30 receptor targeted therapeutics |
CN110511278A (zh) | 2012-05-07 | 2019-11-29 | 达特茅斯大学理事会 | 抗b7-h6抗体、融合蛋白及其使用方法 |
UA114108C2 (uk) | 2012-07-10 | 2017-04-25 | Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем | Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання |
SG11202002636PA (en) * | 2017-09-29 | 2020-04-29 | The United States Of America As Represented By The Secretary | T cell receptors recognizing mutated p53 |
WO2019069125A1 (en) | 2017-10-06 | 2019-04-11 | Oslo Universitetssykehus Hf | CHIMERIC ANTIGEN RECEPTORS |
CN108060135A (zh) * | 2017-12-26 | 2018-05-22 | 东莞赛尔生物科技有限公司 | 一种高效表达p53抑癌蛋白的t细胞、制备方法及应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4867973A (en) * | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
US5057313A (en) * | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
WO1988007553A1 (en) * | 1987-03-26 | 1988-10-06 | Teijin Limited | Process for preparing antibody complex |
AU656518B2 (en) * | 1990-02-20 | 1995-02-09 | Coulter Corporation | Improved antibody-enzyme direct conjugates and method of making same |
GB9200417D0 (en) * | 1992-01-09 | 1992-02-26 | Bagshawe Kenneth D | Cytotoxic drug therapy |
US6399368B1 (en) * | 1992-01-17 | 2002-06-04 | Board Of Regents, The University Of Texas System | Secretion of T cell receptor fragments from recombinant Escherichia coli cells |
DE69326064T2 (de) * | 1992-05-26 | 2000-05-25 | Rijksuniversiteit Te Leiden Le | Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten |
AU5670194A (en) * | 1992-11-20 | 1994-06-22 | Enzon, Inc. | Linker for linked fusion polypeptides |
JPH10503379A (ja) | 1994-07-29 | 1998-03-31 | デイド・インターナショナル・インコーポレーテッド | Mhc複合体およびその用途 |
WO1996013593A2 (en) | 1994-10-26 | 1996-05-09 | Procept, Inc. | Soluble single chain t cell receptors |
JPH10510988A (ja) * | 1994-12-14 | 1998-10-27 | ザ スクリップス リサーチ インスティテュート | 腫瘍−特異的細胞毒性t細胞のインビボ活性化 |
US5830755A (en) * | 1995-03-27 | 1998-11-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | T-cell receptors and their use in therapeutic and diagnostic methods |
US5869270A (en) | 1996-01-31 | 1999-02-09 | Sunol Molecular Corporation | Single chain MHC complexes and uses thereof |
AU728794B2 (en) | 1996-03-05 | 2001-01-18 | Scripps Research Institute, The | Recombinant constructs encoding T cell receptors specific for human HLA-restricted tumor antigens |
US6127524A (en) | 1996-10-18 | 2000-10-03 | Dade Behring Inc. | Binding molecules and computer-based methods of increasing the binding affinity thereof |
AU6685698A (en) | 1997-03-07 | 1998-09-22 | Sunol Molecular Corporation | Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
JP2001519143A (ja) | 1997-10-02 | 2001-10-23 | スノル・モレキュラー・コーポレーション | 可溶性の一本鎖t細胞レセプタータンパク質 |
ATE370967T1 (de) | 1998-10-21 | 2007-09-15 | Altor Bioscience Corp | Polyspezifische bindemoleküle und deren verwendung |
EP1287363A2 (de) | 2000-05-25 | 2003-03-05 | Sunol Molecular Corporation | Modulation von wechselwirkungen in t-zellrezeptoren |
EP1289564B1 (de) | 2000-06-05 | 2018-07-18 | Altor BioScience Corporation | T-zell-rezeptor fusionen und konjugate und verfahren zu deren verwendung |
DE10109855A1 (de) * | 2001-03-01 | 2002-09-12 | Stanislawski Thomas | Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung |
-
2002
- 2002-06-05 DE DE60228504T patent/DE60228504D1/de not_active Expired - Lifetime
- 2002-06-05 CA CA2487779A patent/CA2487779C/en not_active Expired - Lifetime
- 2002-06-05 US US10/163,084 patent/US7456263B2/en not_active Expired - Lifetime
- 2002-06-05 EP EP08012635A patent/EP2009019A1/de not_active Withdrawn
- 2002-06-05 AU AU2002316190A patent/AU2002316190B8/en not_active Expired
- 2002-06-05 EP EP02746470A patent/EP1546188B1/de not_active Expired - Lifetime
- 2002-06-05 AT AT02746470T patent/ATE405582T1/de active
- 2002-06-05 DK DK02746470T patent/DK1546188T3/da active
- 2002-06-05 ES ES02746470T patent/ES2307770T3/es not_active Expired - Lifetime
- 2002-06-05 WO PCT/US2002/017785 patent/WO2004018619A2/en active Application Filing
- 2002-06-05 CN CN028153030A patent/CN1692124B/zh not_active Expired - Lifetime
- 2002-06-05 JP JP2004530731A patent/JP4447456B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2002316190B2 (en) | 2009-01-22 |
EP1546188A2 (de) | 2005-06-29 |
EP1546188B1 (de) | 2008-08-20 |
AU2002316190A1 (en) | 2004-03-17 |
CA2487779A1 (en) | 2004-03-04 |
EP1546188A4 (de) | 2005-12-21 |
CN1692124B (zh) | 2012-05-30 |
WO2004018619A2 (en) | 2004-03-04 |
AU2002316190B8 (en) | 2009-01-29 |
US7456263B2 (en) | 2008-11-25 |
DK1546188T3 (da) | 2008-10-27 |
AU2002316190A8 (en) | 2004-04-08 |
CN1692124A (zh) | 2005-11-02 |
CA2487779C (en) | 2012-10-02 |
DE60228504D1 (de) | 2008-10-02 |
WO2004018619A3 (en) | 2005-05-06 |
EP2009019A1 (de) | 2008-12-31 |
US20080269113A1 (en) | 2008-10-30 |
JP4447456B2 (ja) | 2010-04-07 |
JP2005525128A (ja) | 2005-08-25 |
ES2307770T3 (es) | 2008-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE370967T1 (de) | Polyspezifische bindemoleküle und deren verwendung | |
DE69730693D1 (de) | Mhc-komplexe und ihre verwendungen | |
ATE454159T1 (de) | Von survivin abgeleitete peptide und deren verwendung | |
ATE405582T1 (de) | P53 bindende t-zellrezeptormoleküle und deren verwendungen | |
ATE533784T1 (de) | Lösliche, einzelkettige proteine des t- zellrezeptors | |
DK0643726T3 (da) | Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei | |
CY1108083T1 (el) | Αντιγονα και συνθεσεις του neisseria meningitidis | |
UA98295C2 (ru) | Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla) | |
EP1724282A3 (de) | Verfahren zur Herstellung von nicht-immunogenen Proteinen | |
NO20053304D0 (no) | NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse. | |
ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
NO20034588L (no) | Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider | |
DE69931482D1 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
ATE207459T1 (de) | O-malonyltyrosyl-verbindungen, o-malonyltyrosyl- verbindungen enthaltende peptide und ihre verwendung | |
HUP0301812A2 (hu) | Átvizsgálási (screening) eljárás | |
ATE336579T1 (de) | Isolierte mhc-klasse ii-bindende peptide, und deren verwendung | |
DK1622929T3 (da) | Apo-2L (TRAIL) receptorbindingspeptider og anvendelser deraf | |
CA2270877A1 (en) | Peptide-based immunotherapeutic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1546188 Country of ref document: EP |